Alternatives to Nomic Bio — Nomic is doing for proteins what Illumina has done for DNA
Researchers searching for Nomic Bio alternatives often need cost-effective proteomics solutions that deliver absolute quantification without sacrificing plexity or turnaround speed. Nomic Bio stands out with its $50-per-sample Omni 1000 offering and nELISA-based multiplexing that profiles over 1000 proteins from the secretome or plasma with high specificity. Alternatives typically range from mass spectrometry services that provide broader coverage at higher per-sample cost and slower timelines, to bead-based or aptamer platforms that trade absolute quantification for higher plexity. Users evaluating replacements frequently compare panel flexibility, lot-to-lot reproducibility under 10% CV, and the ability to run thousands of samples per week. The best Nomic Bio alternatives balance these factors while fitting specific study scales in drug discovery or translational immunology work.
Olink ExploreOlink Explore uses proximity extension assay technology for high-plex protein biomarker discovery across thousands of targets. It excels in large population studies with strong reproducibility but typically charges higher per-sample fees than Nomic Bio and provides relative rather than absolute quantification. Turnaround can extend beyond Nomic's one-week service for equivalent cohort sizes.
SomaScanSomaScan employs aptamer-based capture for broad proteome profiling of over 7000 proteins from small sample volumes. It offers exceptional depth for discovery but lacks Nomic Bio's absolute quantification, lower cost structure, and rapid high-throughput service model suited to functional secretome studies.
Luminex xMAPLuminex bead-based multiplexing supports customizable panels up to several hundred analytes with widespread lab adoption. While flexible, it generally shows lower specificity than nELISA and requires more manual workflow, making it less ideal than Nomic for large-scale absolute quantification projects.
Quanterix Simoa delivers ultra-sensitive single-molecule detection for low-abundance proteins, often used in neurology and immunology. It provides excellent sensitivity but at higher cost per sample and lower plexity than Omni 1000, limiting its use for broad affordable profiling.
Traditional ELISA kits from Thermo Fisher offer validated single or low-plex protein measurements with absolute quantification. They remain cost-effective for small studies yet cannot match Nomic Bio's multiplexing scale, throughput, or panel flexibility for discovery workflows.
MSD electrochemiluminescence assays enable multiplex detection with good dynamic range and sensitivity. The platform supports custom panels but typically involves higher instrumentation costs and slower processing than Nomic's automated service for thousands of samples.
Abcam FirePlexAbcam FirePlex provides bead-based multiplex immunoassays focused on inflammation and oncology markers. It offers solid reproducibility for mid-plex work but lacks the absolute quantification, cost efficiency at scale, and secretome-optimized library found in Nomic Omni 1000.
Bio-Rad Bio-Plex systems run Luminex-style bead assays for cytokine and signaling protein panels. While accessible for many labs, they require more hands-on time and deliver lower throughput than Nomic's fully automated nELISA service with expert analysis included.
RayBiotech QuantibodyRayBiotech Quantibody arrays allow glass-slide based multiplex ELISA with absolute quantification for custom or pre-made panels. The format suits smaller studies but scales poorly compared with Nomic for high-volume projects needing rapid turnaround and consistent lot CVs under 10%.
Proteome Sciences offers mass spectrometry-based proteomics services with broad coverage and biomarker expertise. While strong for unbiased discovery, the approach is slower and more expensive per sample than Nomic Bio's targeted, affordable, absolute-quantified nELISA platform for translational cohorts.